Mersana Therapeutics to Host Third Quarter 2023 Conference Call on November 7, 2023

Rhea-AI Summary

Mersana Therapeutics, Inc. will provide business updates and report its financial results for Q3 2023 on November 7, 2023. The company will host a conference call and webcast at 8:00 a.m. Eastern Time. A live webcast will be available on the Mersana website.

CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it will provide business updates and report its financial results for the third quarter ended September 30, 2023 on Tuesday, November 7, 2023. The company will host a conference call and webcast at 8:00 a.m. Eastern Time that morning.

To access the call, please dial 877-270-2148 (domestic) or 412-902-6510 (international). A live webcast of the presentation will be available on the Investors & Media section of the Mersana website at www.mersana.com, and a replay of the webcast will be available in the same location following the conference call for approximately 90 days.

About Mersana Therapeutics
Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel antibody-drug conjugates (ADCs) and driven by the knowledge that patients are waiting for new treatment options. The company has developed proprietary cytotoxic (Dolasynthen) and immunostimulatory (Immunosynthen) ADC platforms that are generating a pipeline of wholly-owned and partnered product candidates with the potential to treat a range of cancers. Its pipeline includes XMT-1660, a Dolasynthen ADC targeting B7-H4, and XMT-2056, an Immunosynthen ADC targeting a novel epitope of human epidermal growth factor receptor 2 (HER2). Mersana routinely posts information that may be useful to investors on the “Investors & Media” section of its website at www.mersana.com.

Contact:
Jason Fredette
617-498-0020
jason.fredette@mersana.com

FAQ

When will Mersana Therapeutics report its financial results for Q3 2023?

Mersana Therapeutics will report its financial results for the third quarter ended September 30, 2023 on Tuesday, November 7, 2023.

What time will the conference call and webcast start?

The conference call and webcast will start at 8:00 a.m. Eastern Time.

How can I access the conference call?

To access the conference call, please dial 877-270-2148 (domestic) or 412-902-6510 (international).

Where can I watch the live webcast of the presentation?

The live webcast of the presentation will be available on the Investors & Media section of the Mersana website at www.mersana.com.

Will there be a replay of the webcast?

Yes, a replay of the webcast will be available in the Investors & Media section of the Mersana website for approximately 90 days following the conference call.